[French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening]

I Sermet-Gaudelus1, A Munck, M Rota

  • 1Inserm U 845, centre de ressources et de compétences de la mucoviscidose, hôpital Necker, université René Descartes, 156, rue de Vaugirard, 75730 Paris, France. isabelle.sermet@nck.aphp.fr

Insights

Standardized sweat testing guidelines for newborn cystic fibrosis (CF) screening are now in place. These procedures ensure accurate diagnosis based on sweat chloride levels, aiding early intervention for CF.

Area of Science:

  • Pediatrics
  • Medical Diagnostics
  • Genetics

Context:

  • Newborn screening protocols are crucial for early detection of genetic disorders.
  • Cystic Fibrosis (CF) diagnosis relies heavily on accurate sweat testing.
  • Standardization of procedures ensures consistency and reliability in diagnostic testing.

Purpose:

  • To establish standardized operating procedures for the sweat test in newborn cystic fibrosis screening.
  • To provide clear diagnostic criteria based on sweat chloride levels.
  • To guide the national Neonatal Screening working group in France.

Summary:

  • Guidelines recommend sweat testing for infants over 3 kg and 3 weeks old.
  • Pilocarpine iontophoresis stimulates sweat secretion, collected via Macroduct coil.
  • Diagnostic criteria: <30 mmol/l likely rules out CF, ≥60 mmol/l supports CF diagnosis, 30-60 mmol/l is abnormal.

Impact:

  • Improved standardization of cystic fibrosis screening across neonatal units.
  • Facilitates earlier and more accurate diagnosis of CF in newborns.
  • Enhances the effectiveness of national newborn screening programs for CF.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...